Page 1

Q3 Trading Statement For the period to 31 December 2020 Embargoed until 7:00 am on 28 January 2021 Very Positive Momentum in Fundraising and Deployment Intermediate Capital Group plc ( ICG or the Group ) provides an update for the period to 31 December 2020 . Highlights Strong fundraising momentum continues : € 2.0bn of Third Party AUM raised during the quarter . Fundraising for the full financial year expected to exceed € 6bn , significantly ahead of our initial expectations for an off - cycle year Third Party AUM of € 44.5bn : increase of 2 % during the quarter and 12 % since 31 December 2019 ■ Significant deployment : € 2.1bn invested in the quarter and € 6.2bn since 31 December 2019 ■ Portfolio performing well : benefitting from continued improvement in underlying performance , valuation environment , and underpinned by selective realisations ■ Well capitalised balance sheet : £ 898m of available liquidity at 31 December 2020 ESG - linked £ 550m RCF signed after the quarter end : refinancing existing facilities and further enhancing our long - standing focus on our broader positive impact on society Commenting , Benoit Durteste , CEO , said : " We maintained very positive momentum in our business through the third quarter , raising significant Third Party AUM and deploying a substantial amount of capital across all our strategic asset classes . " Two of our flagship funds , Europe Fund VII and Strategic Equity III , were particularly active , and we were also pleased to see ongoing deployment in our more recently launched strategies such as Infrastructure Equity and Sale and Leaseback . " Looking forward , we are well positioned to continue this trajectory . Our deployment rate and the performance of our funds through 2020 gives us confidence in our fundraising pipeline , and we are experiencing strong client demand for our strategies . Our global platform and our funds ' abilities to invest across the capital structure are strategic advantages to ICG , particularly at this point in the cycle , and we continue to invest in our capabilities to accelerate our future growth , most recently adding a Life Sciences team to enhance our capability in the Healthcare sector . " While remaining alert to the current macro uncertainty , I am encouraged by the momentum I see across the business and I am looking forward to ICG continuing to deliver significant long - term growth and shareholder value . " 1